Clinical Trials on 多发性骨软骨瘤 in Sweden
总计258个结果
-
Karolinska InstitutetPatient-Centered Outcomes Research Institute; Kaiser Foundation Research Institute主动,不招人
-
Anders SvenningssonVästerbotten County Council, Sweden完全的
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.尚未招聘
-
Karolinska Institutet完全的
-
Linkoeping UniversityCHU Dijon Bourgogne; Hospitaux Universitaires Paris Sud; Hôpital Dupuytren; CHU George Pompidou,... 和其他合作者招聘中
-
Karolinska InstitutetThe Swedish Research Council; Region Stockholm; Swedish Council for Working Life and Social Research 和其他合作者完全的
-
Haukeland University HospitalOslo University Hospital; University Hospital of North Norway; Helse Stavanger HF; St. Olavs Hospital 和其他合作者主动,不招人
-
Uppsala UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University Hospital,... 和其他合作者完全的
-
Karolinska InstitutetKarolinska University Hospital招聘中
-
Biogen完全的复发缓解型多发性硬化症比利时, 丹麦, 芬兰, 荷兰, 挪威, 瑞典, 瑞士, 英国
-
Region StockholmKarolinska Institutet招聘中
-
Uppsala UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University Hospital,... 和其他合作者完全的
-
Karolinska InstitutetSanofi; XNK Therapeutics AB, Sweden招聘中
-
GlaxoSmithKline终止复发/难治性多发性骨髓瘤澳大利亚, 瑞典, 加拿大
-
Karolinska University Hospital完全的
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research Council完全的
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and Uusimaa完全的
-
Karolinska InstitutetKarolinska University Hospital招聘中
-
Merck KGaA, Darmstadt, Germany完全的多发性硬化症 | 复发缓解型瑞典, 德国
-
Uppsala University招聘中
-
Eli Lilly and CompanyBioMS Technology Corp.完全的
-
Biogen完全的
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research Council完全的
-
Eli Lilly and CompanyBioMS Technology Corp.终止